Cargando…
Senescence during early differentiation reduced the chondrogenic differentiation capacity of mesenchymal progenitor cells
Introduction: Mesenchymal stromal/progenitor cells (MSCs) are promising for cartilage cell-based therapies due to their chondrogenic differentiation capacity. However, MSCs can become senescent during in vitro expansion, a state characterized by stable cell cycle arrest, metabolic alterations, and s...
Autores principales: | Voskamp, Chantal, Koevoet, Wendy J. L. M., Van Osch, Gerjo J. V. M., Narcisi, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441241/ https://www.ncbi.nlm.nih.gov/pubmed/37609111 http://dx.doi.org/10.3389/fbioe.2023.1241338 |
Ejemplares similares
-
Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment
por: Voskamp, Chantal, et al.
Publicado: (2020) -
Angiogenic Potential of Tissue Engineered Cartilage From Human Mesenchymal Stem Cells Is Modulated by Indian Hedgehog and Serpin E1
por: Nossin, Yannick, et al.
Publicado: (2020) -
Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells
por: Groeneveldt, Lisanne C., et al.
Publicado: (2014) -
Chondrogenic differentiation of mesenchymal stem cells through cartilage matrix-inspired surface coatings
por: Zhao, Mingyan, et al.
Publicado: (2022) -
Nanocellulose-Based Scaffolds for Chondrogenic Differentiation and Expansion
por: Szustak, Marcin, et al.
Publicado: (2021)